Area lab company buys British firm in $390 million deal

Fort Myers-based NeoGenomics made its first investment into the firm in May 2020.

  • By Business Observer Staff
  • | 10:20 a.m. May 7, 2021
File. NeoGenomics CEO Mark Mallon.
File. NeoGenomics CEO Mark Mallon.
  • Charlotte–Lee–Collier
  • Share

FORT MYERS — Leading cancer-focused genetic testing services firm NeoGenomics has acquired a British-based liquid biopsy firm, Inivata.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news
Subscribe

Already subscribed? Sign in.

Latest News

  • September 10, 2026
Legal troubles mount as REIT founders indicted for stealing from employees
  • September 10, 2026
Trendy Miami cafe opens new location in Water Street Tampa
  • September 10, 2026
Former Pinellas, Lee tourism chief enters Florida Hall of Fame
  • September 10, 2026
40 acres in north Manatee for possible ‘residential rezoning’ listed for sale

Sponsored Content